Seshu Tyagarajan's most recent trade in Candel Therapeutics Inc was a trade of 31,278 Common Stock done at an average price of $8.8 . Disclosure was reported to the exchange on March 17, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Candel Therapeutics Inc | Seshu Tyagarajan | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 8.82 per share. | 17 Mar 2025 | 31,278 | 85,512 | - | 8.8 | 275,947 | Common Stock |
| Candel Therapeutics Inc | Seshu Tyagarajan | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 8.82 per share. | 17 Mar 2025 | 31,278 | 85,512 | - | 8.8 | 275,947 | Common Stock |
| Candel Therapeutics Inc | Seshu Tyagarajan | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Mar 2025 | 20,000 | 70,000 | - | - | Stock Option (Right to Buy) | |
| Candel Therapeutics Inc | Seshu Tyagarajan | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Mar 2025 | 20,000 | 70,000 | - | - | Stock Option (Right to Buy) | |
| Candel Therapeutics Inc | Seshu Tyagarajan | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.29 per share. | 17 Mar 2025 | 20,000 | 116,790 | - | 1.3 | 25,800 | Common Stock |
| Candel Therapeutics Inc | Seshu Tyagarajan | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | |
| Candel Therapeutics Inc | Seshu Tyagarajan | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 7.22 per share. | 15 Jan 2025 | 14,322 | 96,790 | - | 7.2 | 103,476 | Common Stock |
| Candel Therapeutics Inc | Tyagarajan Seshu | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 4.56 per share. | 29 Nov 2024 | 20,392 | 125,657 | - | 4.6 | 92,898 | Common Stock |
| Candel Therapeutics Inc | Tyagarajan Seshu | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 6.47 per share. | 17 Jul 2024 | 14,851 | 146,049 | - | 6.5 | 96,125 | Common Stock |
| Candel Therapeutics Inc | Seshu Tyagarajan | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 5.97 per share. | 11 Jul 2024 | 13,330 | 160,900 | - | 6.0 | 79,625 | Common Stock |
| Candel Therapeutics Inc | Seshu Tyagarajan | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2023 | 90,000 | 90,000 | - | - | Stock Option (Right to Buy) | |
| Candel Therapeutics Inc | Seshu Tyagarajan | Chief Technology Officer | Purchase of securities on an exchange or from another person at price $ 1.93 per share. | 08 Dec 2022 | 10,358 | 13,358 | - | 1.9 | 19,991 | Common Stock |
| Candel Therapeutics Inc | Seshu Tyagarajan | Chief Technology Officer | Purchase of securities on an exchange or from another person at price $ 1.69 per share. | 08 Dec 2022 | 3,000 | 3,000 | - | 1.7 | 5,070 | Common Stock |
| Candel Therapeutics Inc | Seshu Tyagarajan | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Nov 2022 | 73,684 | 73,684 | - | 0 | Common Stock | |
| Candel Therapeutics Inc | Seshu Tyagarajan | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Apr 2022 | 120,000 | 120,000 | - | - | Stock Option (Right to Buy) |